z-logo
Premium
Accounting for uncertainty in confounder and effect modifier selection when estimating average causal effects in generalized linear models
Author(s) -
Wang Chi,
Dominici Francesca,
Parmigiani Giovanni,
Zigler Corwin Matthew
Publication year - 2015
Publication title -
biometrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.298
H-Index - 130
eISSN - 1541-0420
pISSN - 0006-341X
DOI - 10.1111/biom.12315
Subject(s) - confounding , covariate , observational study , statistics , econometrics , sample size determination , bayesian probability , population , causal inference , selection bias , medicine , mathematics , environmental health
Summary Confounder selection and adjustment are essential elements of assessing the causal effect of an exposure or treatment in observational studies. Building upon work by Wang et al. (2012, Biometrics 68 , 661–671) and Lefebvre et al. (2014, Statistics in Medicine 33 , 2797–2813), we propose and evaluate a Bayesian method to estimate average causal effects in studies with a large number of potential confounders, relatively few observations, likely interactions between confounders and the exposure of interest, and uncertainty on which confounders and interaction terms should be included. Our method is applicable across all exposures and outcomes that can be handled through generalized linear models. In this general setting, estimation of the average causal effect is different from estimation of the exposure coefficient in the outcome model due to noncollapsibility. We implement a Bayesian bootstrap procedure to integrate over the distribution of potential confounders and to estimate the causal effect. Our method permits estimation of both the overall population causal effect and effects in specified subpopulations, providing clear characterization of heterogeneous exposure effects that may vary considerably across different covariate profiles. Simulation studies demonstrate that the proposed method performs well in small sample size situations with 100–150 observations and 50 covariates. The method is applied to data on 15,060 US Medicare beneficiaries diagnosed with a malignant brain tumor between 2000 and 2009 to evaluate whether surgery reduces hospital readmissions within 30 days of diagnosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here